HEADER VIRAL PROTEIN 09-JUN-22 5SQA TITLE PANDDA ANALYSIS GROUP DEPOSITION -- CRYSTAL STRUCTURE OF SARS-COV-2 TITLE 2 NSP3 MACRODOMAIN IN COMPLEX WITH Z5010894395 - (R,R) AND (S,S) TITLE 3 ISOMERS COMPND MOL_ID: 1; COMPND 2 MOLECULE: NON-STRUCTURAL PROTEIN 3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NSP3, PL2-PRO, PAPAIN-LIKE PROTEASE, PAPAIN-LIKE PROTEINASE, COMPND 5 PL-PRO; COMPND 6 EC: 3.4.19.121, 3.4.22.-; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: HIS6 PURIFICATION TAG AND LINKER COMPND 9 (MHHHHHHSSGVDLGTENLYFQ) CLEAVED WITH TEV PROTEASE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: REP, 1A-1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET22B(+) KEYWDS MACRODOMAIN, ADP-RIBOSE, SARS-COV-2, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR G.J.CORREY,J.S.FRASER REVDAT 3 20-SEP-23 5SQA 1 JRNL REVDAT 2 26-OCT-22 5SQA 1 JRNL REVDAT 1 06-JUL-22 5SQA 0 JRNL AUTH S.GAHBAUER,G.J.CORREY,M.SCHULLER,M.P.FERLA,Y.U.DORUK, JRNL AUTH 2 M.RACHMAN,T.WU,M.DIOLAITI,S.WANG,R.J.NEITZ,D.FEARON, JRNL AUTH 3 D.S.RADCHENKO,Y.S.MOROZ,J.J.IRWIN,A.R.RENSLO,J.C.TAYLOR, JRNL AUTH 4 J.E.GESTWICKI,F.VON DELFT,A.ASHWORTH,I.AHEL,B.K.SHOICHET, JRNL AUTH 5 J.S.FRASER JRNL TITL ITERATIVE COMPUTATIONAL DESIGN AND CRYSTALLOGRAPHIC JRNL TITL 2 SCREENING IDENTIFIES POTENT INHIBITORS TARGETING THE NSP3 JRNL TITL 3 MACRODOMAIN OF SARS-COV-2. JRNL REF PROC.NATL.ACAD.SCI.USA V. 120 31120 2023 JRNL REFN ESSN 1091-6490 JRNL PMID 36598939 JRNL DOI 10.1073/PNAS.2212931120 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.GAHBAUER,G.J.CORREY,M.SCHULLER,M.P.FERLA,Y.U.DORUK, REMARK 1 AUTH 2 M.RACHMAN,T.WU,M.DIOLAITI,S.WANG,R.J.NEITZ,D.FEARON, REMARK 1 AUTH 3 D.RADCHENKO,Y.MOROZ,J.J.IRWIN,A.R.RENSLO,J.C.TAYLOR, REMARK 1 AUTH 4 J.E.GESTWICKI,F.VON DELFT,A.ASHWORTH,I.AHEL,B.K.SHOICHET, REMARK 1 AUTH 5 J.S.FRASER REMARK 1 TITL STRUCTURE-BASED INHIBITOR OPTIMIZATION FOR THE NSP3 REMARK 1 TITL 2 MACRODOMAIN OF SARS-COV-2. REMARK 1 REF BIORXIV 2022 REMARK 1 REFN ISSN 2692-8205 REMARK 1 PMID 35794891 REMARK 1 DOI 10.1101/2022.06.27.497816 REMARK 2 REMARK 2 RESOLUTION. 1.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.69 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 141627 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.141 REMARK 3 R VALUE (WORKING SET) : 0.140 REMARK 3 FREE R VALUE : 0.158 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.830 REMARK 3 FREE R VALUE TEST SET COUNT : 6837 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.6900 - 3.2700 0.99 4663 232 0.1420 0.1607 REMARK 3 2 3.2700 - 2.5900 0.99 4557 218 0.1400 0.1567 REMARK 3 3 2.5900 - 2.2700 0.99 4523 240 0.1365 0.1520 REMARK 3 4 2.2700 - 2.0600 1.00 4500 250 0.1283 0.1350 REMARK 3 5 2.0600 - 1.9100 0.99 4529 226 0.1310 0.1325 REMARK 3 6 1.9100 - 1.8000 1.00 4479 247 0.1305 0.1587 REMARK 3 7 1.8000 - 1.7100 1.00 4517 210 0.1303 0.1466 REMARK 3 8 1.7100 - 1.6300 1.00 4537 219 0.1257 0.1389 REMARK 3 9 1.6300 - 1.5700 1.00 4476 234 0.1195 0.1415 REMARK 3 10 1.5700 - 1.5200 1.00 4484 249 0.1215 0.1389 REMARK 3 11 1.5200 - 1.4700 1.00 4519 211 0.1212 0.1351 REMARK 3 12 1.4700 - 1.4300 1.00 4494 230 0.1272 0.1522 REMARK 3 13 1.4300 - 1.3900 1.00 4534 219 0.1339 0.1601 REMARK 3 14 1.3900 - 1.3600 1.00 4476 206 0.1372 0.1813 REMARK 3 15 1.3600 - 1.3300 1.00 4482 244 0.1456 0.1560 REMARK 3 16 1.3300 - 1.3000 1.00 4467 249 0.1434 0.1728 REMARK 3 17 1.3000 - 1.2700 1.00 4470 233 0.1423 0.1587 REMARK 3 18 1.2700 - 1.2500 0.99 4490 206 0.1437 0.1783 REMARK 3 19 1.2500 - 1.2300 1.00 4496 221 0.1444 0.1814 REMARK 3 20 1.2300 - 1.2000 1.00 4476 224 0.1448 0.1692 REMARK 3 21 1.2000 - 1.1800 1.00 4440 228 0.1443 0.1788 REMARK 3 22 1.1800 - 1.1700 1.00 4494 230 0.1547 0.1825 REMARK 3 23 1.1700 - 1.1500 1.00 4514 234 0.1602 0.2015 REMARK 3 24 1.1500 - 1.1300 1.00 4492 213 0.1719 0.1851 REMARK 3 25 1.1300 - 1.1200 1.00 4465 207 0.1809 0.2061 REMARK 3 26 1.1200 - 1.1000 1.00 4476 242 0.1940 0.2016 REMARK 3 27 1.1000 - 1.0900 1.00 4469 220 0.2045 0.2294 REMARK 3 28 1.0900 - 1.0800 1.00 4494 220 0.2243 0.2593 REMARK 3 29 1.0800 - 1.0600 1.00 4464 201 0.2433 0.2800 REMARK 3 30 1.0600 - 1.0500 0.97 4313 274 0.2809 0.2906 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.100 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.210 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5SQA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1001404829. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-SEP-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.88557 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS JAN 10, 2022 REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 141674 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.050 REMARK 200 RESOLUTION RANGE LOW (A) : 39.690 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.495 REMARK 200 R MERGE (I) : 0.03400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.3700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 6.31 REMARK 200 R MERGE FOR SHELL (I) : 0.56300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.980 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 27.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.72 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM CHES, 28% PEG 3000, PH 9.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 19.68450 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 29.52675 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 9.84225 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 MET A 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HZ3 LYS A 102 O HOH A 303 1.34 REMARK 500 HZ2 LYS B 44 O HOH B 203 1.50 REMARK 500 O HOH A 338 O HOH B 211 1.88 REMARK 500 O GLN A 107 O HOH A 301 1.89 REMARK 500 O HOH B 368 O HOH B 408 1.90 REMARK 500 O HOH B 393 O HOH B 407 1.93 REMARK 500 O LEU B 169 O HOH B 201 1.96 REMARK 500 O HOH A 464 O HOH A 538 1.97 REMARK 500 O HOH A 351 O HOH A 484 1.97 REMARK 500 O HOH A 516 O HOH A 548 2.02 REMARK 500 NZ LYS A 158 O HOH A 302 2.03 REMARK 500 O HOH A 314 O HOH A 407 2.04 REMARK 500 OH TYR B 42 O HOH B 202 2.05 REMARK 500 O HOH A 500 O HOH A 517 2.06 REMARK 500 O HOH A 354 O HOH B 283 2.08 REMARK 500 NZ LYS B 44 O HOH B 203 2.11 REMARK 500 NZ LYS A 102 O HOH A 303 2.11 REMARK 500 OE2 GLU A 26 O HOH A 304 2.12 REMARK 500 O HOH B 353 O HOH B 370 2.12 REMARK 500 O HOH A 363 O HOH A 375 2.14 REMARK 500 O GLN A 107 O HOH A 301 2.16 REMARK 500 O HOH B 380 O HOH B 415 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 86 -132.04 55.09 REMARK 500 SER B 5 79.01 -100.02 REMARK 500 HIS B 86 -127.89 55.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 589 DISTANCE = 6.04 ANGSTROMS REMARK 525 HOH A 590 DISTANCE = 6.69 ANGSTROMS DBREF 5SQA A 3 169 UNP P0DTD1 R1AB_SARS2 1025 1191 DBREF 5SQA B 3 169 UNP P0DTD1 R1AB_SARS2 1025 1191 SEQADV 5SQA SER A 1 UNP P0DTD1 EXPRESSION TAG SEQADV 5SQA MET A 2 UNP P0DTD1 EXPRESSION TAG SEQADV 5SQA SER B 1 UNP P0DTD1 EXPRESSION TAG SEQADV 5SQA MET B 2 UNP P0DTD1 EXPRESSION TAG SEQRES 1 A 169 SER MET VAL ASN SER PHE SER GLY TYR LEU LYS LEU THR SEQRES 2 A 169 ASP ASN VAL TYR ILE LYS ASN ALA ASP ILE VAL GLU GLU SEQRES 3 A 169 ALA LYS LYS VAL LYS PRO THR VAL VAL VAL ASN ALA ALA SEQRES 4 A 169 ASN VAL TYR LEU LYS HIS GLY GLY GLY VAL ALA GLY ALA SEQRES 5 A 169 LEU ASN LYS ALA THR ASN ASN ALA MET GLN VAL GLU SER SEQRES 6 A 169 ASP ASP TYR ILE ALA THR ASN GLY PRO LEU LYS VAL GLY SEQRES 7 A 169 GLY SER CYS VAL LEU SER GLY HIS ASN LEU ALA LYS HIS SEQRES 8 A 169 CYS LEU HIS VAL VAL GLY PRO ASN VAL ASN LYS GLY GLU SEQRES 9 A 169 ASP ILE GLN LEU LEU LYS SER ALA TYR GLU ASN PHE ASN SEQRES 10 A 169 GLN HIS GLU VAL LEU LEU ALA PRO LEU LEU SER ALA GLY SEQRES 11 A 169 ILE PHE GLY ALA ASP PRO ILE HIS SER LEU ARG VAL CYS SEQRES 12 A 169 VAL ASP THR VAL ARG THR ASN VAL TYR LEU ALA VAL PHE SEQRES 13 A 169 ASP LYS ASN LEU TYR ASP LYS LEU VAL SER SER PHE LEU SEQRES 1 B 169 SER MET VAL ASN SER PHE SER GLY TYR LEU LYS LEU THR SEQRES 2 B 169 ASP ASN VAL TYR ILE LYS ASN ALA ASP ILE VAL GLU GLU SEQRES 3 B 169 ALA LYS LYS VAL LYS PRO THR VAL VAL VAL ASN ALA ALA SEQRES 4 B 169 ASN VAL TYR LEU LYS HIS GLY GLY GLY VAL ALA GLY ALA SEQRES 5 B 169 LEU ASN LYS ALA THR ASN ASN ALA MET GLN VAL GLU SER SEQRES 6 B 169 ASP ASP TYR ILE ALA THR ASN GLY PRO LEU LYS VAL GLY SEQRES 7 B 169 GLY SER CYS VAL LEU SER GLY HIS ASN LEU ALA LYS HIS SEQRES 8 B 169 CYS LEU HIS VAL VAL GLY PRO ASN VAL ASN LYS GLY GLU SEQRES 9 B 169 ASP ILE GLN LEU LEU LYS SER ALA TYR GLU ASN PHE ASN SEQRES 10 B 169 GLN HIS GLU VAL LEU LEU ALA PRO LEU LEU SER ALA GLY SEQRES 11 B 169 ILE PHE GLY ALA ASP PRO ILE HIS SER LEU ARG VAL CYS SEQRES 12 B 169 VAL ASP THR VAL ARG THR ASN VAL TYR LEU ALA VAL PHE SEQRES 13 B 169 ASP LYS ASN LEU TYR ASP LYS LEU VAL SER SER PHE LEU HET QNF A 201 42 HET QNV A 202 42 HET QNV A 203 42 HETNAM QNF (1R,2R)-4-HYDROXY-1-[(3-OXO-3,4-DIHYDRO-2H-1,4- HETNAM 2 QNF BENZOXAZINE-7-CARBONYL)AMINO]-2,3-DIHYDRO-1H-INDENE-2- HETNAM 3 QNF CARBOXYLIC ACID HETNAM QNV (1S,2S)-4-HYDROXY-1-[(3-OXO-3,4-DIHYDRO-2H-1,4- HETNAM 2 QNV BENZOXAZINE-7-CARBONYL)AMINO]-2,3-DIHYDRO-1H-INDENE-2- HETNAM 3 QNV CARBOXYLIC ACID FORMUL 3 QNF C19 H16 N2 O6 FORMUL 4 QNV 2(C19 H16 N2 O6) FORMUL 6 HOH *519(H2 O) HELIX 1 AA1 ASP A 22 LYS A 31 1 10 HELIX 2 AA2 GLY A 47 THR A 57 1 11 HELIX 3 AA3 ASN A 59 GLY A 73 1 15 HELIX 4 AA4 ASN A 99 GLY A 103 5 5 HELIX 5 AA5 GLN A 107 ASN A 115 1 9 HELIX 6 AA6 PHE A 116 HIS A 119 5 4 HELIX 7 AA7 ALA A 129 GLY A 133 5 5 HELIX 8 AA8 ASP A 135 VAL A 147 1 13 HELIX 9 AA9 ASP A 157 SER A 167 1 11 HELIX 10 AB1 ASP B 22 LYS B 31 1 10 HELIX 11 AB2 GLY B 47 THR B 57 1 11 HELIX 12 AB3 ASN B 59 GLY B 73 1 15 HELIX 13 AB4 ASN B 99 GLY B 103 5 5 HELIX 14 AB5 ASP B 105 GLN B 107 5 3 HELIX 15 AB6 LEU B 108 ASN B 115 1 8 HELIX 16 AB7 PHE B 116 HIS B 119 5 4 HELIX 17 AB8 ALA B 129 GLY B 133 5 5 HELIX 18 AB9 ASP B 135 VAL B 147 1 13 HELIX 19 AC1 ASP B 157 LEU B 169 1 13 SHEET 1 AA1 4 LEU A 10 LYS A 11 0 SHEET 2 AA1 4 VAL A 16 ASN A 20 -1 O ILE A 18 N LEU A 10 SHEET 3 AA1 4 ASN A 150 VAL A 155 1 O LEU A 153 N TYR A 17 SHEET 4 AA1 4 VAL A 121 ALA A 124 1 N LEU A 122 O TYR A 152 SHEET 1 AA2 3 VAL A 34 ALA A 38 0 SHEET 2 AA2 3 HIS A 91 VAL A 95 1 O VAL A 95 N ASN A 37 SHEET 3 AA2 3 SER A 80 SER A 84 -1 N LEU A 83 O CYS A 92 SHEET 1 AA3 4 LEU B 10 LYS B 11 0 SHEET 2 AA3 4 VAL B 16 ASN B 20 -1 O ILE B 18 N LEU B 10 SHEET 3 AA3 4 ASN B 150 VAL B 155 1 O LEU B 153 N TYR B 17 SHEET 4 AA3 4 VAL B 121 ALA B 124 1 N ALA B 124 O TYR B 152 SHEET 1 AA4 3 VAL B 34 ALA B 38 0 SHEET 2 AA4 3 HIS B 91 VAL B 95 1 O LEU B 93 N ASN B 37 SHEET 3 AA4 3 SER B 80 SER B 84 -1 N CYS B 81 O HIS B 94 CRYST1 88.747 88.747 39.369 90.00 90.00 90.00 P 43 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011268 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011268 0.000000 0.00000 SCALE3 0.000000 0.000000 0.025401 0.00000